Facilitated By

San Antonio Medical Foundation

Research Project Qualification Form

207 Results Page 10 of 21

The Role of Follistatin Like-1 Protein in Coronary Aneurisms of Kawasaki Disease

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Patterson, Jean
Funded by
William & Ella Owens Medical Research Foundation

The major goal of this project, using a model of Kawasaki disease in mice, is to selectively turn off the FSTL-1 gene at different times during the onset and development of the disease, and evaluate if, and how, FSTL-1 affects the heart damage seen in Kawasaki disease in order to develop an effective treatment strategy for Kawasaki disease's long term effects.

Active Project
Cardiovascular
Basic Research

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Assess Cardiovascular Outcomes Following Treatment With Ertugliflozin (Mk-8835/PF-04971729) In Subjects With Type 2 Diabetes Mellitus And Established Vascular Disease

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
GENEVA

The Overall Study Sponsor has developed a study to evaluate the cardiovascular safety of ertugliflozin compared with a non-ertugliflozin comparator group and to assess the safety and tolerability of ertugliflozin and its effects on measures of glycemic control, blood pressure, body weight, renal function and albuminuria

Active Project
Cardiovascular
Clinical Care

PHASE 3 MULTI-CENTER, DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP EVALUATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF BOCOCIZUMAB (PF-04950615) IN REDUCING THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN HIGH RISK PATIENTS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Bailey,Steven R
Funded by
PFIZER
Active Project
Cardiovascular
Clinical Care
Drug Discovery

G PROTEIN COUPLED ESTROGEN RECEPTOR1 AND ISCHEMIA/REPERFUSION INJURY

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Bopassa,Jean C
Funded by
VOELCKER FUND
Active Project
Cardiovascular
Basic Research

PROTECTIVE EFFICACY OF ASTROCYTE MITOCHONDRIA IN HUMAN BRAIN TISSUE

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Lechleiter,James D
Funded by
WILLIAM & ELLA OWENS MED RSCH FOUNDATION
Active Project
Cardiovascular
Neuroscience
Basic Research

CELLULAR SENESCENCE DUE TO INVASIVE PNEUMOCOCCAL DISEASE LEADS TO CARDIAC INTERSTITIAL FIBROSIS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Chapman,Claude T
Funded by
AMERICAN HEART ASSOC - SOUTHWEST AFFIL
Active Project
Cardiovascular
Infectious Disease
Clinical Care

A RANDOMIZED, DOUBLE-BLIND, EVENT-DRIVEN, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE EFFECTS OF CANAGLIFLOZIN ON RENAL AND CARDIOVASCULAR OUTCOMES IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND DIABETIC NEPHROPATHY (CREDENCE TRIAL)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Hura,Claudia E.
Funded by
JANSSEN PHARMACEUTICA RESEARCH FOUNDATIO
Active Project
Cardiovascular
Diabetes and Obesity
Clinical Care
Drug Discovery

AVERT TRIAL

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Prasad,Anand
Funded by
OSPREY MEDICAL
Active Project
Cardiovascular
Clinical Care
Drug Discovery

PRE-CLINICAL EVALUATION OF ANTHRACYCLINE EQUIVALENCY

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Aune,Gregory
Funded by
THE PABLOVE FOUNDATION
Active Project
Cancer
Cardiovascular
Basic Research

HIGH DOSE ALDOSTERONE ANTAGONIST FOR ACUTE DECOMPENSATED HEART FAILURE

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Bansal,Shweta
Funded by
RELYPSA
Active Project
Cardiovascular
Clinical Care
Drug Discovery